HedgeChatter

  • Home /
  • Tag Archives

VSTM

Dr. Paul A. Friedman Joins Verastem Board of Directors

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the appointment of Paul A. Friedman, M.D. moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Dr. Paul A. Friedman Joins Verastem Board of Directors read more

Verastem Announces Initiation of COMMAND Study in Japan

[Business Wire] – CAMBRIDGE, Mass.–(BUSINESSWIRE)– Verastem, Inc. (NASDAQ:VSTM – News), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here […]

May 12, 2014 Bystocknews , Comments Off on Verastem Announces Initiation of COMMAND Study in Japan read more

Verastem reports Q1 EPS (51c), consensus (43c)

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on Verastem reports Q1 EPS (51c), consensus (43c) read more

Verastem Reports First Quarter 2014 Financial and Corporate Results

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the fir moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on Verastem Reports First Quarter 2014 Financial and Corporate Results read more

Verastem: Cancer May Have Met Its Match

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

April 20, 2014 Bystocknews , Comments Off on Verastem: Cancer May Have Met Its Match read more

4:02 pm Verastem reports data from Phase 1 study of VS-6063 (defactinib) in Japanese patients: well tolerated, meets study objectives

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

March 6, 2014 Bystocknews , Comments Off on 4:02 pm Verastem reports data from Phase 1 study of VS-6063 (defactinib) in Japanese patients: well tolerated, meets study objectives read more